Bioenergetics
6 min read•Archived in Dallas2.json & Interview_0912_2250.json
The Precursor Paradox: Why NR and NMN Stumble Without Baseline ATP
The biochemical flaw in oral precursor supplementation: synthesizing NAD+ from NR or NMN requires ATP. When an exhausted cell is depleted of NAD+, it lacks the ATP needed to convert the precursors.
“If you look at those complicated pathways of NAD being produced by NR and NMN, you need ATP there to stimulate the final production. But if you don't have enough NAD initially, you won't have the ATP to accomplish that.”
— Dr. Fenton LeBon, MD, MBA
Core Scientific Takeaways
- Precursors like Nicotinamide Riboside (NR) and Nicotinamide Mononucleotide (NMN) are not finished NAD+.
- The enzymatic salvage pathway consumes cellular ATP to synthesize NAD+.
- Severely depleted cells suffer an 'energetic catch-22' where they cannot afford the ATP cost to convert precursors.
- Direct bioavailable routes bypass metabolic conversion bottlenecks.
The Precursor Catch-22
Converting NMN into NAD+ requires the enzyme NMNAT, which consumes ATP: $$\text{NMN} + \text{ATP} \xrightarrow{\text{NMNAT}} \text{NAD}^+ + \text{PP}_i$$If a fatigued individual has depleted mitochondria, their cells lack the ATP required to execute this reaction. Expecting an energy-starved cell to spend its non-existent ATP reserves to synthesize NAD+ creates a metabolic roadblock. nanoNAD+™ delivers finished, single-molecule Beta-NAD+ directly into circulation.Related Teachings in Bioenergetics
Peptides & Blueprints
Peptides: The Blueprint — Instructions That Tell Your Cells What To Do
Read Teaching
Molecular PurityThe Upstream NAD-Glutathione Axis: Why Glutathione Requires Hydride Loading
Read Teaching
BioenergeticsThe Crude Oil & Refinery Hierarchy: Why NAD+ and Mitochondria Cannot Be Separated
Read Teaching